Jo Vercammen

1.5k total citations
19 papers, 1.2k citations indexed

About

Jo Vercammen is a scholar working on Molecular Biology, Infectious Diseases and Virology. According to data from OpenAlex, Jo Vercammen has authored 19 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 7 papers in Infectious Diseases and 7 papers in Virology. Recurrent topics in Jo Vercammen's work include HIV Research and Treatment (7 papers), HIV/AIDS drug development and treatment (7 papers) and Advanced Fluorescence Microscopy Techniques (4 papers). Jo Vercammen is often cited by papers focused on HIV Research and Treatment (7 papers), HIV/AIDS drug development and treatment (7 papers) and Advanced Fluorescence Microscopy Techniques (4 papers). Jo Vercammen collaborates with scholars based in Belgium, Czechia and Italy. Jo Vercammen's co-authors include Yves Engelborghs, Zeger Debyser, Frauke Christ, Jelle Hendrix, Stéphane Emiliani, Katrien Busschots, Richard Bénarous, Marijke Stigter‐van Walsum, Maria J.W.D. Vosjan and Joost A. Kolkman and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Physical Chemistry B and Journal of Virology.

In The Last Decade

Jo Vercammen

19 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jo Vercammen Belgium 15 721 407 365 133 131 19 1.2k
Wataru Nomura Japan 20 769 1.1× 436 1.1× 387 1.1× 200 1.5× 22 0.2× 89 1.4k
Donald H. Burke United States 29 2.1k 3.0× 197 0.5× 194 0.5× 89 0.7× 30 0.2× 84 2.4k
Yves Mély France 20 714 1.0× 417 1.0× 252 0.7× 152 1.1× 52 0.4× 26 1.1k
John J. Dwyer United States 12 783 1.1× 265 0.7× 228 0.6× 134 1.0× 9 0.1× 13 1.1k
Waldemar Schrimpf Germany 14 370 0.5× 58 0.1× 64 0.2× 199 1.5× 119 0.9× 16 786
Marc C. Deller United States 14 828 1.1× 665 1.6× 265 0.7× 128 1.0× 7 0.1× 18 1.5k
Derek Hudson United States 15 1.6k 2.2× 216 0.5× 96 0.3× 117 0.9× 7 0.1× 27 2.0k
Gerhard Krauss Germany 23 1.3k 1.8× 66 0.2× 68 0.2× 90 0.7× 22 0.2× 45 1.5k
Michaela Wendeler United States 18 548 0.8× 127 0.3× 160 0.4× 26 0.2× 11 0.1× 37 858
Brian C. Froehler United States 22 2.3k 3.2× 57 0.1× 183 0.5× 35 0.3× 22 0.2× 31 2.5k

Countries citing papers authored by Jo Vercammen

Since Specialization
Citations

This map shows the geographic impact of Jo Vercammen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jo Vercammen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jo Vercammen more than expected).

Fields of papers citing papers by Jo Vercammen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jo Vercammen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jo Vercammen. The network helps show where Jo Vercammen may publish in the future.

Co-authorship network of co-authors of Jo Vercammen

This figure shows the co-authorship network connecting the top 25 collaborators of Jo Vercammen. A scholar is included among the top collaborators of Jo Vercammen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jo Vercammen. Jo Vercammen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Vosjan, Maria J.W.D., Jo Vercammen, Joost A. Kolkman, et al.. (2012). Nanobodies Targeting the Hepatocyte Growth Factor: Potential New Drugs for Molecular Cancer Therapy. Molecular Cancer Therapeutics. 11(4). 1017–1025. 115 indexed citations
2.
Buyens, Kevin, Bart Lucas, Koen Raemdonck, et al.. (2007). A fast and sensitive method for measuring the integrity of siRNA-carrier complexes in full human serum. Journal of Controlled Release. 126(1). 67–76. 111 indexed citations
3.
Hombrouck, Anneleen, Barbara Van Remoortel, Jo Vercammen, et al.. (2007). Selection of human immunodeficiency virus type 1 resistance against the pyranodipyrimidine V-165 points to a multimodal mechanism of action. Journal of Antimicrobial Chemotherapy. 59(6). 1084–1095. 13 indexed citations
4.
Tintori, Cristina, Fabrizio Manetti, Nevena Veljković, et al.. (2007). Novel Virtual Screening Protocol Based on the Combined Use of Molecular Modeling and Electron-Ion Interaction Potential Techniques To Design HIV-1 Integrase Inhibitors. Journal of Chemical Information and Modeling. 47(4). 1536–1544. 19 indexed citations
5.
Rijck, Jan De, Linos Vandekerckhove, Rik Gijsbers, et al.. (2006). Overexpression of the Lens Epithelium-Derived Growth Factor/p75 Integrase Binding Domain Inhibits Human Immunodeficiency Virus Replication. Journal of Virology. 80(23). 11498–11509. 135 indexed citations
6.
Humpolíčková, Jana, Ellen Gielen, Aleš Benda, et al.. (2006). Probing Diffusion Laws within Cellular Membranes by Z-Scan Fluorescence Correlation Spectroscopy. Biophysical Journal. 91(3). L23–L25. 104 indexed citations
7.
Gielen, Ellen, Jo Vercammen, Jan Sýkora, et al.. (2005). Diffusion of sphingomyelin and myelin oligodendrocyte glycoprotein in the membrane of OLN-93 oligodendroglial cells studied by fluorescence correlation spectroscopy. Comptes Rendus Biologies. 328(12). 1057–1064. 9 indexed citations
8.
Busschots, Katrien, Jo Vercammen, Stéphane Emiliani, et al.. (2005). The Interaction of LEDGF/p75 with Integrase Is Lentivirus-specific and Promotes DNA Binding. Journal of Biological Chemistry. 280(18). 17841–17847. 168 indexed citations
9.
Geys, Jorina, Lieve Coenegrachts, Jo Vercammen, et al.. (2005). In vitro study of the pulmonary translocation of nanoparticles. Toxicology Letters. 160(3). 218–226. 91 indexed citations
10.
Witvrouw, Myriam, Valery Fikkert, Jo Vercammen, et al.. (2005). Identification of Authentic Inhibitors of HIV-1 Integration. Lirias (KU Leuven). 4(2). 153–165. 9 indexed citations
11.
Maertens, Goedele N., Jo Vercammen, Zeger Debyser, & Yves Engelborghs. (2005). Measuring protein‐protein interactions inside living cells using single color fluorescence correlation spectroscopy. Application to human immunodeficiency virus type 1 integrase and LEDGF/p75. The FASEB Journal. 19(8). 1039–1041. 33 indexed citations
12.
13.
Witvrouw, Myriam, Bénédicte Van Maele, Jo Vercammen, et al.. (2004). Novel Inhibitors of HIV-1 Integration. Current Drug Metabolism. 5(4). 291–304. 45 indexed citations
14.
Verstrepen, Kevin J., Stijn D. M. Van Laere, Jo Vercammen, et al.. (2004). The Saccharomyces cerevisiae alcohol acetyl transferase Atf1p is localized in lipid particles. Yeast. 21(4). 367–377. 57 indexed citations
15.
Verheijen, Wendy, Johan Hofkens, Jo Vercammen, et al.. (2004). The Photo Physical Properties of Dendrimers Containing 1,4‐Dioxo‐3,6‐Diphenylpyrrolo[3,4‐c]pyrrole (DPP) as a Core. Macromolecular Chemistry and Physics. 206(1). 25–32. 19 indexed citations
16.
Margineanu, Anca, Johan Hofkens, Mircea Cotlet, et al.. (2004). Photophysics of a Water−Soluble Rylene Dye:  Comparison with Other Fluorescent Molecules for Biological Applications. The Journal of Physical Chemistry B. 108(32). 12242–12251. 95 indexed citations
17.
Fikkert, Valery, Bénédicte Van Maele, Jo Vercammen, et al.. (2003). Development of Resistance against Diketo Derivatives of Human Immunodeficiency Virus Type 1 by Progressive Accumulation of Integrase Mutations. Journal of Virology. 77(21). 11459–11470. 80 indexed citations
18.
Vercammen, Jo, Goedele N. Maertens, Melanie Gérard, et al.. (2002). DNA-induced Polymerization of HIV-1 Integrase Analyzed with Fluorescence Fluctuation Spectroscopy. Journal of Biological Chemistry. 277(41). 38045–38052. 30 indexed citations
19.
Craenenbroeck, Elke Van, Jo Vercammen, Gunther Matthys, et al.. (2001). Heuristic Statistical Analysis of Fluorescence Fluctuation Data with Bright Spikes: Application to Ligand Binding to the Human Serotonin Receptor Expressed in Escherichia coli Cells. Biological Chemistry. 382(3). 355–361. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Wataru Nomura Breakdown of academic impact, for papers by Donald H. Burke Breakdown of academic impact, for papers by Yves Mély Breakdown of academic impact, for papers by John J. Dwyer Breakdown of academic impact, for papers by Waldemar Schrimpf Breakdown of academic impact, for papers by Marc C. Deller Breakdown of academic impact, for papers by Derek Hudson Breakdown of academic impact, for papers by Gerhard Krauss Breakdown of academic impact, for papers by Michaela Wendeler Breakdown of academic impact, for papers by Brian C. Froehler
Rankless by CCL
2026